Extracorporeal Shock Wave Therapy (ESWT) for Muscoloskeletal Conditions and Soft Tissue Wounds 2.01.31
Summary
Extracorporeal shock wave therapy (ESWT) for musculoskeletal conditions, including chronic plantar fasciitis, tendinitis of the shoulder and elbow, and non-union of fractures, is considered investigational. ESWT as a treatment for wound healing is also considered investigational. The FDA regulates ESWT devices, and ESWT is not addressed in National or Regional Medicare coverage determinations.
Get alerts when payers change rules like this one
We check Excellus BlueCross BlueShield and other payers every day and email you when a change matches your specialty and state.